Pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 18 Nov 2026, 20:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.9
- Combined market value
- CZK 112.5T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | CZK 128B | CZK 188.14 | 1.91% down | 1% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | CZK 518.3B | CZK 452.07 | 0.54% down | 96% up | ||
| 3 | GSKGSK · Health Care | 2.2 | CZK 2.17T | CZK 1,081.05 | 1.22% down | 6% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | CZK 2.52T | CZK 1,048.04 | 0.79% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | CZK 1.51T | CZK 472.18 | 1.83% down | 54% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | CZK 169B | CZK 485.18 | 3.36% up | 83% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | CZK 2.71T | CZK 1,324.81 | 2.84% down | 34% up | ||
| 8 | PfizerPFE · Health Care | 2.6 | CZK 3.55T | CZK 622.98 | 1.55% down | 14% up | ||
| 9 | Elanco Animal HealthELAN · Health Care | 2.8 | CZK 297.5B | CZK 595.20 | 3.60% up | 20% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.9 | CZK 1.09T | CZK 937.69 | 1.01% down | 74% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.9 | CZK 111.4B | CZK 1,333.86 | 0.57% down | 20% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.1 | CZK 70.5B | CZK 363.61 | 1.55% up | 42% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | CZK 277.6B | CZK 332.94 | 1.28% up | 5% up | ||
| 14 | ZoetisZTS · Health Care | 3.7 | CZK 773.1B | CZK 1,902.73 | 2.55% up | 29% down | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | CZK 265B | CZK 1,367.98 | 5.20% up | 11% up | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | CZK 351.4B | CZK 5,473.92 | 2.32% up | 37% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.8 | CZK 3.87T | CZK 877.35 | 3.01% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | CZK 4.03T | CZK 2,326.57 | 0.03% down | 17% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.7 | CZK 6.16T | CZK 3,973.92 | 1.90% down | 2% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | CZK 102.3B | CZK 614.31 | 2.52% up | 64% down | ||
| 21 | Merck & CoMRK · Health Care | 5.2 | CZK 7.55T | CZK 3,061.12 | 3.93% down | 51% up | ||
| 22 | AlkermesALKS · Health Care | 5.3 | CZK 174.6B | CZK 1,039.15 | 2.87% up | 58% up | ||
| 23 | NovartisNVS · Health Care | 5.4 | CZK 6.52T | CZK 3,452.29 | 2.39% down | 25% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | CZK 444.7B | CZK 3,320.38 | 4.54% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | CZK 2.17T | CZK 21,016.88 | 1.27% down | 36% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 7.0 | CZK 14.61T | CZK 6,070.23 | 2.00% down | 38% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | CZK 135.7B | CZK 959.59 | 0.43% up | 10% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.7 | CZK 547.9B | CZK 12,865.01 | 0.90% down | 23% up | ||
| 29 | AbbVieABBV · Health Care | 8.3 | CZK 11.23T | CZK 6,353.05 | 2.38% down | 26% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | CZK 700.3B | CZK 1,135.72 | 1.66% down | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.6 | CZK 1.02T | CZK 8,960.43 | 2.44% down | 17% up | ||
| 32 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | CZK 204.5B | CZK 8,801.52 | 6.16% down | 24% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | 9.7 | CZK 165B | CZK 1,507.33 | 3.21% down | 8% down | ||
| 34 | Travere TherapeuticsTVTX · Health Care | 9.8 | CZK 106.8B | CZK 1,112.61 | 2.04% down | 44% up | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | CZK 165.6B | CZK 2,107.20 | 0.32% down | 126% up | ||
| 36 | Axsome TherapeuticsAXSM · Health Care | 11.0 | CZK 156.1B | CZK 2,968.44 | 1.76% down | 7% down | ||
| 37 | Vertex PharmaceuticalsVRTX · Health Care | 11.4 | CZK 3.03T | CZK 11,952.43 | 0.67% up | 27% up | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 11.5 | CZK 133.7B | CZK 2,048.08 | 0.22% up | 31% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 16.2 | CZK 221.7B | CZK 1,466.88 | 5.25% up | 107% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.6 | CZK 877.2B | CZK 1,525.56 | 0.06% down | 78% up | ||
| 41 | Eli LillyLLY · Health Care | 18.9 | CZK 27.4T | CZK 30,756.76 | 2.24% down | 35% up | ||
| 42 | Ascendis PharmaASND · Health Care | 22.2 | CZK 393.8B | CZK 6,002.89 | 0.41% down | 28% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | CZK 132.8B | CZK 6,640.09 | 1.68% up | 43% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.1 | CZK 336.3B | CZK 1,726.59 | 1.15% up | 17% up | ||
| 45 | InsmedINSM · Health Care | 43.3 | CZK 583.5B | CZK 2,659.95 | 1.79% down | 40% down | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | 43.6 | CZK 183.9B | CZK 2,652.06 | 2.33% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | 81.1 | CZK 158.7B | CZK 1,138.95 | 0.78% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 180 | CZK 183.8B | CZK 2,816.64 | 1.65% up | 46% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2321 | CZK 105B | CZK 1,864.94 | 3.53% down | 113% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3394 | CZK 623.1B | CZK 859.90 | 0.05% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2255 CZK). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 pharmaceutical companies ranked here as of 18 Nov 2026, 20:50 UTC.
How many pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 50 pharmaceutical companies ranked by P/S ratio have a combined market value of CZK 112.5T as of 18 Nov 2026, 20:50 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.